Clinical Scorecard: Seamless Incorporation of a National Rare Disease Registry into a Data Warehouse for Rare Eye Conditions: A Study on Implementation
At a Glance
Category
Detail
Condition
Rare Eye Diseases (RED)
Key Mechanisms
Integration of clinical data from expert centers into a centralized data warehouse (FREDD) for research purposes.
Target Population
Patients with rare eye diseases in France.
Care Setting
Expert clinical centers and research institutions.
Key Highlights
FREDD is designed to support the secondary use of clinical data from patients with RED.
The integration of BaMaRa data into FREDD minimizes inconsistencies and streamlines data updates.
FREDDEX automates the extraction, transformation, and loading of data from BaMaRa to FREDD.
Guideline-Based Recommendations
Diagnosis
Utilize standardized clinical information collected through BaMaRa and FREDD.
Management
Implement interoperability standards to enhance data sharing among rare disease registries.
Monitoring & Follow-up
Leverage data from FREDD for epidemiological monitoring and research.
Risks
Potential for redundant or overlapping diagnostic data due to multiple data entry modes.
Patient & Prescribing Data
Patients with rare eye diseases receiving care at specialized centers.
Data collected in FREDD will support projects utilizing artificial intelligence for diagnosis and treatment.
Clinical Best Practices
Ensure data consistency by automating data retrieval from existing databases.
Adopt harmonized codification schemes for rare disease data.
Background music and multimedia exposure were associated with lower patient-reported anxiety in a quasi-experimental ophthalmology clinic study that used existing clinic audiovisual infrastructure at no additional cost.
